2016BloodRequires access

Clinical impact of MYD88 mutations in chronic lymphocytic leukemia

Alejandra Martínez‐Trillos, Alba Navarro, Marta Aymerich, Julio Delgado, Armando López‐Guillermo, Elı́as Campo, Neus Villamor

Open publisher page 10 citations

Abstract

To the editor: We have read with interest the letter by Baliakas et al[1][1] on the impact of MYD88 mutation in IGHV mutated (M-IGHV) chronic lymphocytic leukemia (CLL) patients. They reported a frequency of MYD88 -mutated patients of 4% in a series of 558 M-IGHV CLL, and found that M-IGHV CLL

About this research paper

What this paper is about

To the editor: We have read with interest the letter by Baliakas et al[1][1] on the impact of MYD88 mutation in IGHV mutated (M-IGHV) chronic lymphocytic leukemia (CLL) patients. They reported a frequency of MYD88 -mutated patients of 4% in a series of 558 M-IGHV CLL, and found that M-IGHV CLL

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the editor: We have read with interest the letter by Baliakas et al[1][1] on the impact of MYD88 mutation in IGHV mutated (M-IGHV) chronic lymphocytic leukemia (CLL) patients. They reported a frequency of MYD88 -mutated patients of 4% in a series of 558 M-IGHV CLL, and found that M-IGHV CLL

Key concepts: IGHV@, Chronic lymphocytic leukemia, Mutation, Leukemia, Cancer research, Biology, Immunology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical impact of MYD88 mutations in chronic lymphocytic leukemia — Research Paper | ScholarLens